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Anesthesia for cesarean section in the dog
Abstract
The major goal in anesthesia for cesarean section (CS) is to minimize fetal effects of anesthetic drugs in order
to minimize fetal respiratory, central nervous system and cardiovascular depression and deliver live, vigorous
puppies. Of equal importance is to provide adequate analgesia to the dam and prevent anesthesia-related
complications such as hypotension, hypoventilation, hypoxemia, hemorrhage and hypothermia, which will
increase morbidity and mortality in both mother and puppies. The physiochemical properties which allow
drugs to cross the blood-brain barrier also facilitate crossing of the placenta, therefore the assumption should
be made (with very few exceptions) that anes- thetics, analgesics and sedatives/tranquilizers all cross the
placenta. Prolonged labor prior to delivery causes maternal physiologic compromise, resulting in fetal
depression due to decreased placental perfusion, hypoxemia and acidosis. Maternal and puppy mortality is
significantly increased during emergent versus planned CS (1,2). Timing and preparation are extremely
impor- tant for puppy survival for both elective and emergency CS, and a thorough understanding of the
maternal phy- siologic changes and the potential impact of anesthetic drugs is essential to optimize outcomes
for both mother and fetus (Figure 1).
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■ 
Anesthesia for cesarean 
section in the dog
KEY POINTS
•	 The	major	goals	for	cesarean	section	are	to	
deliver	live,	vigorous	puppies	while	providing	
adequate	analgesia	to	the	dam.
•	 There	is	a	higher	anesthetic	risk	with	
cesarean	section	due	to	pregnancy-
associated	physiologic	changes.
•	 Planning	and	preparation	are	important	
for	both	elective	and	emergent	surgical	
scenarios.
•	 Optimized	ventilation,	oxygenation	and	
perfusion	in	the	dam	should	permit	a	“happy	
dam,	happy	baby”	scenario.
•	 Neonatal	resuscitation	centers	on	stimulating	
respiration	and	supporting	oxygenation	and	
body	temperature.
•	 Most	commonly	used	analgesic	drugs	may	
be	safely	administered	to	lactating	dams	
without	adversely	affecting	the	neonates.
 ■ Introduction
The major goal in anesthesia for cesarean section (CS) is 
to minimize fetal effects of anesthetic drugs in order to 
minimize fetal respiratory, central nervous system and 
cardiovascular depression and deliver live, vigorous 
puppies. Of equal importance is to provide adequate 
analgesia to the dam and prevent anesthesia-related 
complications such as hypotension, hypoventilation, 
hypoxemia, hemorrhage and hypothermia, which will 
increase morbidity and mortality in both mother and 
puppies. The physiochemical properties which allow 
drugs to cross the blood-brain barrier also facilitate 
crossing of the placenta, therefore the assumption 
should be made (with very few exceptions) that anes-
thetics, analgesics and sedatives/tranquilizers all cross 
the placenta. Prolonged labor prior to delivery causes 
maternal physiologic compromise, resulting in fetal 
depression due to decreased placental perfusion, 
hypoxemia and acidosis. Maternal and puppy mortality 
is significantly increased during emergent versus planned 
CS (1,2). Timing and preparation are extremely impor-
tant for puppy survival for both elective and emergency 
CS, and a thorough understanding of the maternal phy-
siologic changes and the potential impact of anesthetic 
drugs is essential to optimize outcomes for both mother 
and fetus (Figure 1).
 ■ Maternal physiologic changes
Increased metabolic demands imposed by the fetus 
result in major physiologic changes during pregnancy 
and impact the anesthetic management of these patients 
(Figure 2). Much of the data describing these alterations 
have been obtained in humans and sheep, but should 
be comparable – if not greater in magnitude – in the dog, 
since birth weight as a percentage of maternal weight is 
significantly greater (3). Pregnancy-associated physio-
logic changes to the cardiac, pulmonary and gastroin-
testinal (GI) systems are summarized in Table 1. These 
result in greater anesthetic risk (due to decreased car-
diac and respiratory reserve and a higher chance of 
vomiting/regurgitation with aspiration) as well as de-
creased anesthetic requirements (which may put them 
at risk for anesthetic overdose) (3,4). 
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Cardiovascular 
The growing fetuses increase metabolic demand and 
maternal oxygen consumption. Increases in heart rate 
and stroke volume augment cardiac output by 30-40% 
to meet the demand (3-5), but result in decreased 
cardiac reserve. 
Unlike other major organs, uterine blood flow is not 
auto-regulated (4). Uterine blood flow and placental per-
fusion are directly related to systemic blood pressure 
and inversely proportional to myometrial vascular resis-
tance (3). Decreases in uterine blood flow will result in 
decreased fetal oxygen delivery. Pain, stress, hyperven-
tilation and some drugs (e.g., alpha-2 agonists) can all 
decrease cardiac output during labor and contribute to 
decreased uterine blood flow. Control of pain and anxi-
ety are key components of successful patient manage-
ment. Care must be taken to avoid cardiac depression 
from excessive doses of sedatives or anesthetics. In 
humans, the posterior vena cava and aorta can be 
compressed during dorsal recumbency which decreases 
venous return, cardiac output and uterine blood flow. 
Although less significant in dogs, the amount of time in 
dorsal recumbency should minimized (3,4).
Maternal blood volume during pregnancy increases by 
up to ~23% in dogs, along with red blood cells (RBCs) (6), 
with plasma volume increasing more than RBCs, lead-
ing to decreased packed cell volume. This pregnancy-
associated anemia increases in magnitude in relation to 
the number of fetuses (7). Increased blood volume buffers 
against losses during parturition but can confound the 
use of packed cell volume as a measure of dehydration 
preoperatively; other clinical signs may need to be uti-
lized. There is a greater risk of intra-operative hemorrhage 
due to the increased blood flow to the gravid uterus (20-
40 times normal) and mammary glands (5). Intra-opera-
tive hemorrhage should be quantified and replaced with 
3-4 times the amount in crystalloid solution (up to 10% 
loss of the total blood volume) to avoid the associated 
hypotension and decreased uterine blood flow. Colloid 
therapy should be added if hemorrhage reaches 20%. 
Hypotension may be treated with ephedrine (administered 
as a bolus, 0.03-0.1 mg/kg IV); this is the drug of choice 
in pregnant women since it increases blood pressure 
while maintaining uterine blood flow, whereas both dopa-
mine and dobutamine decrease uterine blood flow (3,4). 
Pulmonary
Tidal volume, respiratory rate and minute ventilation 
all increase, but functional residual capacity (FRC) 
decreases due to craniodorsal displacement of the ab-
dominal organs and diaphragm by the gravid uterus 
(3-5). Decreased FRC leads to small airway closure and 
atelectasis. The combination of decreased FRC and in-
creased oxygen consumption raises the risk of hypox-
emia during periods of hypoventilation or apnea (e.g., 
during anesthetic induction (3,4)). Pre-oxygenation prior 
to anesthetic induction is recommended to delay the 
onset of hypoxemia from approximately 60 seconds to 
up to five minutes if the patient is tolerant (8). 
Figure 1. Maintaining adequate ventilation, oxygenation 
and perfusion in the dam will optimize fetal outcome => 
“Happy dam, Happy baby”.
Figure 2. Pregnancy-associated physiologic changes 
to the cardiac, pulmonary and gastrointestinal systems 
result in greater anesthetic risk due to decreased cardiac 
and respiratory reserve and higher risk of vomiting/
regurgitation and aspiration.    
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Gastrointestinal
Increased serum progesterone decreases lower esopha-
geal sphincter tone, GI motility and gastric emptying, 
whilst cranial displacement of the stomach increases 
intra-gastric pressure; together these contribute to a 
greater risk of regurgitation and aspiration (3,4). In-
creased gastrin and gastric acid production lowers 
stomach pH and puts parturient patients at greater risk 
for aspiration pneumonitis and esophagitis (4). Prophy-
lactic administration of metoclopramide or anti-emetics 
such as maropitant or ondansetron and/or H2 receptor 
antagonists may help ameliorate these effects. Emergent 
patients are also likely to be inadequately fasted, and 
rapid IV induction followed by intubation (ensuring the cuff 
is properly inflated) is recommended. 
Passive regurgitation may occur due to increased intra-
gastric pressure, exacerbated by positive-pressure ven-
tilation or manipulation of the viscera; if this occurs, 
esophageal suction and lavage should be performed 
and 4% sodium bicarbonate infused to increase the pH 
in the lower esophagus (9). 
CNS
The minimum alveolar concentration of inhalant anes-
thetics decreases up to 40% in parturients (3,4). How-
ever, it may be offset by the omission of sedatives/tran-
quilizer premedication. Inhalant-sparing techniques such 
as incision blocks, epidural and parenteral analgesia will 
help avoid high inhalant concentration and reduce fetal 
cardiopulmonary and CNS depression.
 ■ General pharmacology and 
pregnancy
Placental transfer of drugs has been primarily studied in 
sheep and laboratory animals, and direct extrapolation 
to dogs may be misleading due to species differences in 
placentation, extent of placental metabolism and trans-
port of drug across the placenta (4). However, in gen-
eral, the same physiochemical properties that allow 
drugs to cross the blood brain barrier also facilitate their 
placental transfer. The safest assumption is that most, if 
not all, drugs cross the placenta and affect the fetus. 
Elective procedures requiring anesthesia are best 
avoided during the first trimester (20 days of gestation 
in dogs), when the fetuses are most vulnerable to tera-
togenic effects of drugs.
Simple diffusion is the most important mechanism of 
placental transfer of drugs. Properties favoring transfer 
include: 
• Molecular weight < 600 Da
• High lipid solubility
• Low degree of protein binding
• Non-ionization at maternal blood pH (3,4) 
Most anesthetic drugs, with the exception of glycopyr-
rolate and neuromuscular blocking agents, have MW 
< 300 Da and are relatively lipid soluble, and thus readily 
cross the placenta.  
Drug protein binding and degree of ionization is deter-
mined by its pKa and blood pH, which in turn can affect 
the distribution between the dam and fetus. As blood pH 
decreases, acidic drugs such as thiobarbiturates will be 
less ionized and the fraction of drug bound to protein is 
decreased, leading to greater clinical effect (3,4). Weakly 
basic drugs (opioids, local anesthetics) become more 
highly ionized, resulting in less effect on the dam and 
fetus (3,4). Redistribution of drugs out of the fetus back 
into the dam’s circulation as maternal plasma levels 
decrease makes clinical estimation of fetal plasma con-
centrations difficult. Although ~50% of umbilical vein 
blood passes through the fetal liver, microsomal enzyme 
activity and metabolism are minimal (4). 
Table 1. Pregnancy-associated physiologic 
changes.
Cardiovascular
ñHeart rate, stroke volume, 
cardiac output
òVascular tone, arterial blood 
pressure
ñOxygen consumption
ñRed blood cells, blood/plasma 
volume
òPacked cell volume/hemoglobin/
plasma proteins
Respiratory
ñRespiratory rate, tidal volume, 
minute ventilation
òFunctional residual capacity
Gastrointestinal
òLower esophageal sphincter 
tone
ñIntra-gastric pressure/gastric 
emptying time
òGI motility, pH of gastric 
secretions
ñGastrin production
Central Nervous 
System ñEndorphins
A N E S T H E S I A  F O R  C E S A R E A N  S E C T I O N  I N  T H E  D O G
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Inhalant agents readily cross the placenta and should 
be titrated to the lowest level needed to achieve ade-
quate anesthesia. Unlike halothane and methoxyflu-
rane, which rely heavily on metabolism (~20-50% and 
50-75% respectively) for elimination, isoflurane and 
sevoflurane are almost entirely eliminated through the 
respiratory system. Additionally, the low blood solubility 
results in rapid clearance from the newborn as long as 
they are breathing at delivery. It is important to avoid 
high inhalant concentrations to prevent neonatal respi-
ratory depression and apnea. Isoflurane is associated 
with improved puppy survival at 7 days compared to 
methoxyflurane and there is no difference when com-
pared to epidural anesthesia (1).   
Anesthetic drugs 
•  Anticholinergic agents such as atropine and glyco-
pyrrolate are primarily used to decrease vagal tone due 
to opioids or traction on the uterus, or to support fetal 
heart rate. Choice depends on the desire for placental 
transfer, since atropine crosses the placental barrier 
but glycopyrrolate does not. Glycopyrrolate will miti-
gate the increased vagal tone caused by mu agonist 
opioids and prevent maternal bradycardia and possi-
ble hypotension. It also increases gastric pH and may 
decrease the severity of chemical pneumonitis should 
regurgitation and aspiration occur in the dam (3). Fetal 
bradycardia (< 150 beats/min) indicates fetal distress 
and is one of the prime indicators for emergency CS 
(10). Fetal cardiac output is more dependent on heart 
rate than blood pressure. Atropine may be adminis-
tered to the dam if the objective is to increase fetal 
heart rate, which may be low due to hypoxemia, fetal 
distress or mu agonist opioids. Increasing the fetal 
heart rate will increase myocardial oxygen consump-
tion in the face of hypoxemia, which may lead to myo-
cardial ischemia, so atropine use is controversial. 
However, it may support the heart rate long enough to 
allow delivery and proper resuscitation. It is important 
to optimize maternal oxygenation, cardiac output and 
blood pressure, and ensure good ventilation for the 
puppies after delivery.  
•  Tranquilizers/sedatives are typically avoided due to 
cardiorespiratory and CNS depression. Xylazine alone or 
in combination with ketamine is associated with higher 
fetal death (1). Medetomidine at low doses (< 20 µg/kg) 
does not increase uterine muscle activity or cause abor-
tion (3), but both medetomidine and dexmedetomidine 
cause significant decreased cardiac output in the dam 
due to vasoconstriction and baroreceptor-mediated 
bradycardia, and drug label recommendations advise 
against their use in pregnant dogs. Benzodiazepines 
(diazepam and midazolam) can cause neonatal depres-
sion, lethargy, apnea and hypothermia, especially at 
higher doses. Low dose acepromazine may be an 
option for very stressed or anxious dogs to avoid de-
creased uterine blood flow. The drug crosses the pla-
centa slowly due to its higher molecular weight and 
protein binding, and is not associated with increased 
maternal or neonatal mortality (2,4), but its αa-adrenergic 
antagonism can cause vasodilation and therefore it should 
be avoided in dehydrated or compromised patients. 
•  Opioids include mu-receptor agonists such as mor-
phine, hydromorphone, oxymorphone, fentanyl, meth-
adone and meperidine. Buprenorphine is a partial mu 
agonist and butorphanol is a mu-receptor antagonist 
and a kappa agonist. These latter two drugs typically 
produce less sedation and respiratory depression than 
full mu agonists, but offer less potent analgesia. 
Administering opioids to the dam will result in placental 
transfer, the extent of transfer differing depending on 
the drug. Less than 10% of buprenorphine is transferred 
to the fetus, whereas fentanyl (which is highly lipid solu-
ble) crosses the placenta in high amounts, persisting 
long after maternal clearance (4). Of the commonly 
used mu agonists, morphine is the least lipid soluble 
and only 20-30% is non-ionized at normal plasma pH 
(4). It crosses the placenta less rapidly than more lipid 
soluble agonists such as fentanyl. The lipid solubility of 
hydromorphone lies between these two drugs. 
Neonates are significantly more sensitive to CNS and 
respiratory depression of opioids due to the immaturity 
of their CNS, increased permeability of the blood-brain 
barrier and end-organ sensitivity, and even small 
changes in ventilation may lead to hypoxemia and 
increased mortality. Respiratory and CNS depression 
in newly delivered neonates can be reversed with 
naloxone.
 ■ Anesthetic induction
The use of thiopental, ketamine, xylazine and methoxy-
flurane have been associated with increased puppy mor-
tality and/or decreased puppy vigor at birth, and are best 
avoided (1,11,12). Epidural anesthesia/analgesia used 
alone for CS has minimal fetal effects but has various 
drawbacks; it is technically difficult, airway protection 
via intubation is impossible, and there is the risk of hind-
limb paralysis, hypotension or urinary retention (if epidural 
opioids are used).  
28 / Veterinary Focus / Vol 26 n°1 / 2016
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Figure 3 (a and b). Resuscitation equipment and drugs should be organized before induction of anesthesia. 
Propofol has a short half-life and rapid metabolism, 
including extra-hepatic metabolism, but it can cause 
cardiopulmonary depression depending on the dose 
and rate of administration. Propofol followed by isoflu-
rane has puppy survival rates equivalent to epidural 
anesthesia and is associated with a positive effect on 
neonatal survival at 7 days (1). Propofol has similar fetal 
mortality rates to mask induction with isoflurane, but it 
allows IV induction and rapid control and protection of 
the airway (1,13).
Alphaxalone is available in many countries and has 
been shown to have a shorter terminal half-life com-
pared to propofol (14,15). Two recent studies compar-
ing propofol to alphaxalone for induction at CS found no 
significant difference in puppy mortality at 24 hours or 
up to 3 months after delivery, but both studies identified 
differences in “puppy vigor”. Apgar scores and all four 
health vigor assessments (withdrawal, sucking, ano-
genital and flexion reflexes) were greater for puppies for 
up to 60 minutes post-delivery where the dams received 
alphaxalone (16,17). 
 ■ Anesthetic technique
If labor has begun, the puppies are likely to be in some 
degree of distress and the dam may be exhausted and 
dehydrated; crystalloid fluids can be given and may be 
started pre-operatively and continued during surgery to 
save time. An IV catheter can be placed with the aid of a 
local block using an insulin syringe with 18 units of 
lidocaine and 2 units of sodium bicarbonate. Clipping 
and initial surgical preparation of the abdomen can be 
done prior to anesthetic induction. 
As noted above, the increased risk for regurgitation and 
aspiration can be decreased using maropitant (1.0 mg/
kg SC administered at least 30 minutes prior to opioid 
administration (18)). For more emergent situations, ma-
ropitant may be given (1.0 mg/kg IV over 5 minutes while 
monitoring blood pressure) and discomfort on injection 
can be decreased by diluting 50:50 with crystalloid solu-
tion. Alternatively, an opioid premedication which does 
not induce vomiting may be administered (e.g., butor-
phanol at 0.2-0.3 mg/kg IM or IV). Sedatives, e.g., ace-
promazine at 2.0-5.0 µg/kg IM or IV, should be reserved 
for highly stressed dams; however, remember that this 
drug has a long duration of action and cannot be reversed 
in either the dam or puppies.
Premedication with an opioid, either butorphanol or a full 
mu agonist should be administered even to quiet or 
debilitated dams as it decreases pain, stress and the 
induction and inhalant dose requirements. Using a low 
dose may lessen the respiratory and CNS depressant 
effects on the fetuses/neonates. Anti-cholinergics may 
be administered depending on the objective(s) as indi-
cated above. 
Lumbosacral epidural with either local anesthetic or 
opioid (alone or in combination) can be administered 
A N E S T H E S I A  F O R  C E S A R E A N  S E C T I O N  I N  T H E  D O G
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either before or directly after induction to provide anesthesia 
and analgesia. Lidocaine (2.0-3.0 mg/kg, 0.1-0.15 mL/
kg of 20 mg/mL concentration)) will last for ~90 minutes, 
whilst bupivacaine (0.75-1.5 mg/kg, 0.1-0.2 mL/kg of 
7.5 mg/mL concentration) lasts up to 4-6 hours. Both 
drugs will affect hindlimb motor function and may con-
tribute to intra-operative hypotension through sympa-
thetic blockade. Alternatively, preservative-free morphine 
may be used alone to provide analgesia (0.1-0.2 mg/kg); 
the onset of action may take up to 60 minutes, but motor 
function is not affected. Epidural opioids may cause urinary 
retention and – since early hospital discharge is advanta-
geous for healthy dam and puppies – owners must moni-
tor urine output for 24 hours after discharge. The combi-
nation of lidocaine (2.0 mg/kg) and morphine (0.1 mg/kg) 
provides rapid onset of anesthesia along with synergistic 
and long-lasting analgesia. Epidural drug administration 
requires much lower doses than the same drugs given 
parenterally and therefore decreases systemic effects in 
the dam and puppies. Alternatively, the epidural can be 
performed after the pups are delivered and the incision 
is closed to provide post-operative analgesia. 
Pre-oxygenation of the dam (100 mL/kg/min by face mask 
for 3 minutes prior to induction) will prevent hypoxemia 
associated with hypoventilation and apnea at induction. 
Propofol or alphaxalone can be used for anesthesia 
induction, followed by maintenance with isoflurane or 
sevoflurane. Close monitoring of anesthetic depth is rec-
ommended to titrate inhalant to the lowest level that will 
provide adequate anesthesia in the dam. Monitoring of 
ECG, blood pressure, pulse oximetry and end-tidal car-
bon dioxide is recommended to ensure adequate oxy-
genation, ventilation and perfusion in the dam.
If local anesthetic epidural is not performed, a lidocaine 
block along the line of incision (at 2 mg/kg, diluted with 
sterile water if necessary to increase the volume) will pro-
vide intra-operative analgesia. Bupivacaine may be used 
(1.5-2.0 mg/kg) for an incisional block at the time of clo-
sure of the linea alba for longer post-operative analgesia. 
Lidocaine and bupivacaine mixtures have a decreased 
duration of action and are not recommended (19).
If butorphanol is used as a premedication, stronger opi-
oid analgesics such as hydromorphone (0.05-0.1 mg/
kg IV) or morphine (0.5-1.0 mg/kg slowly IV) can be 
administered once the puppies are delivered. Alterna-
tively buprenorphine (0.01-0.02 mg/kg IV) will result in 
less sedation, bradycardia and respiratory depression 
than the full mu agonist, and also offers a much longer 
duration of action (4-10 hours in dogs), but the cost 
may be significantly higher. Milk transfer has not been 
analyzed for opioids, NSAIDs or local anesthetics in lac-
tating dogs. However, breast milk transfer of opioids 
has been well studied in humans and although most 
opioids are excreted in low concentrations in human 
milk they do not pose a significant neonate risk unless 
large or repeated doses are administered (20). NSAID 
safety profiles have not been evaluated in puppies less 
than 4-6 weeks of age, but carprofen is poorly excreted 
and undetectable (< 25 ng/mL) in the milk of lactating 
dairy cattle (21). 
Excretion of lidocaine and bupivacaine and/or their 
metabolites does occur but there is minimal effect on 
human neonates (22) and milk concentrations of ropi-
vacaine are lower than for other local anesthetics (23). 
Although species differences may occur, based on cur-
rent evidence it seems that most commonly used anal-
gesics may be safely administered to lactating dams 
without adversely affecting the neonates.
 ■ Neonate resuscitation
Resuscitation equipment and drugs should be organ-
ized before induction of anesthesia (Table 2, Figure 3) 
with (ideally) one assistant per neonate delivered. 
Resuscitation should center on tactile stimulation of 
Table 2. Neonatal resuscitation equipment list.
•  Oxygen source
•  Small tight-fitting mask
•  Heat source (e.g., circulating water blanket, 
hot air or electric blankets)
•  Clean towels
•  Neonatal bulb syringes
•  1mL or insulin syringes
•  Small (25G) needles
•  Dextrose
•  Crystalloid fluids
•  Monitoring equipment
•  Intubation equipment:
➢- Laryngoscope with small blade (size 0-1)
➢-  Endotracheal tubes (size 2.0-3.0 mm OD,  
14G or 18G IV catheter)
•  Resuscitation drugs:
➢- Naloxone 
➢- Doxapram 
➢- Epinephrine 
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Figure 4. Rub the newborn pup vigorously with clean, 
warm towels to stimulate respiration.
Figure 5. Suction of fluid from mouth and pharynx can be 
accomplished with a neonatal bulb syringe.
Figure 6. The JenChung GV26 acupuncture point used 
to stimulate respiration; a 25G needle is inserted into the 
nasal philtrum until it contacts bone and then twisted.
respiration and maintaining or improving ventilation, 
oxygenation and body temperature. During the normal 
birth process through the pelvic canal, the neonate’s 
chest is compressed, expelling fluid from the respiratory 
tract and stimulating the first breath through recoil of the 
chest wall. This does not occur during cesarean deliv-
ery, therefore immediately after delivery the fetal mem-
branes should be removed, the umbilical cord clamped 
and severed, and the neonate rubbed vigorously with 
clean towels to encourage respiration (Figure 4). Stim-
ulation of the perineal and umbilical areas, and rubbing 
of the hair in a backward direction, may also benefit res-
piration. At the same time, a suction bulb should be 
used to clear the mucous and fluid from the nose, mouth 
and pharynx (Figure 5). A proprietary aspiration/resus-
citation device is available in some countries which clears 
the respiratory tract and stimulates the respiratory reflex. 
Acupuncture can be useful; a 25G needle inserted into 
the nasal philtrum until it contacts bone (the JenChung 
GV26 point) and then twisted can help stimulate respira-
tion (Figure 6). The practice of “swinging” newborns to 
facilitate resuscitation or clearing of fluid from the respi-
ratory tract is not recommended and increases the likeli-
hood of injury (24). 
Spontaneous breathing should be identified by observ-
ing the chest wall, listening for vocalization, or ausculta-
tion with a stethoscope. The two major causes of fetal 
depression are hypoxemia and drugs administered to 
the dam. Vigorous rubbing should continue along with 
oxygen supplementation and gentle chest compres-
sions. Opioids administered to the dam should be 
reversed in the neonate with naloxone (0.002-0.02 mg/
kg IV or 1-2 drops sublingually) after delivery if the pups 
are slow to begin breathing, moving and vocalizing. 
Neonatal heart rates should be ~220 bpm and can be 
counted by palpating a precordial pulse. Bradycardia 
usually indicates hypoxemia and should be treated by 
stimulating ventilation, supplemental oxygen, patient 
warming and mechanical stimulation as described 
above. Doxapram (1-2 drops sublingually) can be used 
as a respiratory stimulant, but it also increases cerebral 
oxygen consumption and should only be used with oxy-
gen supplementation. There is no evidence against 
employing the drug in dogs, but its use has been dis-
continued in humans. If spontaneous breathing is still 
not observed, the pup should be intubated using a 
short-bladed laryngoscope and (depending on the size/
breed) a flexible 14 or 18G IV catheter or 2.0-3.0 OD 
endotracheal tube; careful handling is necessary to 
avoid traumatizing the delicate neonatal tissues. Severe 
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bradycardia or asystole may be treated with epinephrine 
(0.1 µg/kg) diluted with 0.5 mL of crystalloid fluid, and 
administered though the umbilical vein (identified as the 
thin-walled vessel within the umbilical stump; umbilical 
arteries have thicker walls). Thermoregulation reflexes 
are underdeveloped in neonates, therefore as soon as 
the neonate is breathing, moving and vocalizing, they 
should be placed in a warmed incubator. 
